Autism spectrum disorders and mastocytosis (Q48345348)

10 February 2018

editorial

0 references

title

Autism spectrum disorders and mastocytosis (English)

1 reference

10 February 2018

main subject

autism spectrum disorder

0 references

autism

0 references

author

Theoharis C Theoharides

series ordinal

1

object named as

Theoharis C Theoharides

1 reference

10 February 2018

publication date

1 October 2009

1 reference

10 February 2018

International Journal of Immunopathology and Pharmacology

published in

1 reference

10 February 2018

volume

22

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

859-865

1 reference

10 February 2018

Identification and Evaluation of Children With Autism Spectrum Disorders

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Parental report of health conditions and health care use among children with and without autism: National Survey of Children's Health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Epidemiology of Pervasive Developmental Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Autism, gut-blood-brain barrier, and mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Mast cell mediators in allergic inflammation and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Mastocytosis: mediator-related signs and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Mastocytosis: molecular mechanisms and clinical disease heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Atopic features in early childhood autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

The critical role of mast cells in allergy and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Mast cells as effector cells: a co-stimulating question

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Critical role of mast cells in inflammatory diseases and the effect of acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Inflammatory mediators and modulation of blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Elevated immune response in the brain of autistic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Maternal immune activation alters fetal brain development through interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Differential release of mast cell mediators and the pathogenesis of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Neuroglial activation and neuroinflammation in the brain of patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Antibrain antibodies in children with autism and their unaffected siblings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Maternal antibrain antibodies in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Corticotropin-releasing hormone and the blood-brain-barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Autism and immunity: revisited study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

Novel therapeutic targets for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200401

10.1177/039463200902200401

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018